Fertility and Sterility
Volume 91, Issue 6 , Pages 2632-2637 , June 2009

Laparoscopic fertility-sparing staging in unexpected early stage ovarian malignancies

  • Ludovico Muzii, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Campus Biomedico University, Rome, Italy
    • ,
  • Innocenza Palaia, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, “Sapienza” University, Rome, Italy
    • ,
  • Milena Sansone, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, “Sapienza” University, Rome, Italy
    • ,
  • Marco Calcagno, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, “Sapienza” University, Rome, Italy
    • ,
  • Francesco Plotti, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, “Sapienza” University, Rome, Italy
    • ,
  • Roberto Angioli, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Campus Biomedico University, Rome, Italy
    • ,
  • Pierluigi Benedetti Panici, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, “Sapienza” University, Rome, Italy
    • Corresponding Author InformationReprint requests: Pierluigi Benedetti Panici, M.D., Department of Gynecology, Obstetrics and Perinatology, University of Rome “Sapienza,” Viale del Policlinico 155, 00161 Rome, Italy (FAX: 390649972484).

Received 18 January 2008 ,Revised 21 March 2008 ,Accepted 24 March 2008.

References 

  1. Staging announcement. FIGO Cancer Committee. Gynecol Oncol. 1986;50:383–385
  2. Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Torri V, et al. The accuracy of staging: an important prognostic determinator in stage I ovarian carcinoma. A multivariate analysis. Ann Oncol. 1998;9:1097–1101
  3. Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer—Adjuvant ChemoTherapy In Ovarian Neoplasm trial. J Natl Cancer Inst. 2003;95:113–125
  4. Tozzi R, Kohler C, Ferrara A, Schneider A. Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes. Gynecol Oncol. 2004;93:199–203
  5. Maneo A, Vignali M, Chiari S, Colombo A, Mangioni C, Landoni F. Are borderline tumors of the ovary safely treated by laparoscopy?. Gynecol Oncol. 2004;94:387–392
  6. Fauvet R, Boccara J, Dufournet C. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Ann Oncol. 2005;16:403–410
  7. Desfeux P, Camatte S, Chatellier G, Blanc B, Querleu D, Lecuru F. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors. Gynecol Oncol. 2005;98:390–395
  8. Helewa ME, Krepart GV, Lotocki R. Staging laparotomy in early epithelial ovarian carcinoma. Am J Obstet Gynecol. 1986;154:282–286
  9. Yazigi R, Sandstad J, Munoz AK. Primary staging in ovarian tumors of low malignant potential. Gynecol Oncol. 1988;3:402–408
  10. Hopkins MP, Morley GW. The second-look operation and surgical reexploration in ovarian tumor of low malignant potential. Obstet Gynecol. 1989;74:375–378
  11. Snider DD, Stuart GC, Nation JG, Robertson DI. Evaluation of surgical staging in Stage I low malignant potential ovarian tumors. Gynecol Oncol. 1991;40:129–132
  12. Lin PS, Gershenson DM, Bevers MW, Lucas KR, Burke TW, Silva EG. The current status of surgical staging of ovarian serous borderline tumors. Cancer. 1999;85:905–911
  13. Piver MS, Barlow JJ, Shashikant BL. Incidence of subclinical metastases in stage I and II ovarian carcinoma. Obstet Gynecol. 1978;52:100–104
  14. Buchsbaum HJ, Brady MF, Delgado G, Miller A, Hoskins WJ, Manetta A, et al. Surgical staging of carcinoma of the ovaries. Surg Gynecol Obstet. 1989;169:226–232
  15. Young RC, Walton LA, Ellenberg SS, Homesley HD, Wilbanks GD, Decker DG, et al. Adjuvant therapy in stage I and stage LI epithelial ovarian cancer: result of two prospective randomized trials. N Engl J Med. 1990;322:1021–1027
  16. Soper JT, Johnson P, Johnson J, Berchuk A, Clarke-Pearson DL. Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma. Obstet Gynecol. 1992;80:949–953
  17. Stier EA, Barakat RR, Curtin JP. Laparotomy to complete staging of presumed early ovarian cancer. Obstet Gynecol. 1996;87:737–740
  18. Querleu D. Laparoscopic surgical therapy and staging in a case of early malignant granulosa cell tumor of the ovary. Eur J Obstet Gynecol Reprod Biol. 1994;54:215–217
  19. Childers JM, Lang J, Surwit EA, Hatch KD. Laparoscopic surgical staging of ovarian cancer. Gynecol Oncol. 1995;59:25–33
  20. Pomel C, Provencher D, Dauplat J, Gauthier P, Le Bouedec G, Drouin P, et al. Laparoscopic staging of early ovarian cancer. Gynecol Oncol. 1995;58:301–306
  21. Querleu D, Papageorgiou T, Lambaudie E, Sonoda Y, Narducci F, LeBlanc E. Laparoscopic restaging of borderline ovarian tumours: results of 30 cases initially presumed as Stage IA borderline ovarian tumours. BJOG. 2003;110:201–204
  22. Fauvet R, Boccara J, Dufournet C, David-Montefiore E, Poncelet C, Darai E. Restaging surgery for women with borderline ovarian tumors. Results of a French multicenter study. Cancer. 2004;100:1145–1151
  23. Leblanc E, Querleu D, Narduccia F, Occellia B, Papageorgioua T, Sonoda Y. Laparoscopic restaging of early stage invasive adnexal tumors: a 10-year experience. Gynecol Oncol. 2004;94:624–629
  24. Spirtos NM, Eisekop SM, Boike G, Schlaerth JB, Cappellari JO. Laparoscopic staging in patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum: a Gynecologic Oncology Group (GOG) study. Am J Obstet Gynecol. 2005;193:1645–1649
  25. Chi DS, Abu-Rustum NR, Sonoda Y, Ivy J, Rhee E, Moore K, et al. The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers. Am J Obstet Gynecol. 2005;192:1614–1619
  26. Darai E, Tulpin L, Prugnolle H, Cortez A, Dubernard G. Laparoscopic restaging of borderline ovarian tumors. Surg Endosc. 2007;21:2039–2043
  27. Morice P, Camatte S, Wicart-Poque F, Atallah D, Rouzier R, Pautier P, et al. Results of conservative management of epithelial malignant and borderline ovarian tumors. Hum Reprod. 2003;9:185–192
  28. Raspagliesi F, Fontanelli R, Paladini D, di Re EM. Conservative surgery in high-risk epithelial ovarian carcinoma. J Am Coll Surg. 1997;185:457–460
  29. Brown C, Hyman J, Almadrones L, Curtin J, Hoskins W. Conservative surgical management of early epithelial ovarian cancer (EOC). Proc ASCO. 1995;14:766
  30. Morice P, Wicart-Poque F, Rey A, El-Hassan J, Pautier P, Lhommé C. Results of conservative treatment in epithelial ovarian carcinoma. Cancer. 2001;92:2412–2418
  31. Schilder JM, Thompson AM, DePriest PD, Ueland FR, Cibull ML, Kryscio RJ. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol. 2002;87:1–7
  32. Muzii L, Angioli R, Zullo M, Benedetti Panici P. The unexpected ovarian malignancy found during operative laparoscopy: incidence, management, and implications for prognosis. J Min Inv Gyn. 2005;12:81–89
  33. Purola E, Nieminem U. Does rupture of cystic carcinoma during operation influence the prognosis?. Ann Chir Gynaecol Fenn. 1968;57:615–617
  34. Webb MJ, Decker DG, Mussey E, et al. Factor influencing survival in Stage I ovarian cancer. Am J Obstet Gynecol. 1973;116:222–228
  35. Einhorn N, Nilsson B, Sjovall K. Factors influencing survival in carcinoma of the ovary: study from a well-defined Swedish population. Cancer. 1985;55:2019–2025
  36. Dembo A, Davy M, Stenwig AE. Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol. 1990;75:263–273
  37. Sevelda P, Vavra N, Schemper N. Prognostic factors for survival in stage I epithelial ovarian carcinoma. Cancer. 1990;65:2349–2352
  38. Finn CB, Luesley DM, Buxton EJ. Is stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five-year cancer registry review. Br J Obstet Gynecol. 1992;99:54–58
  39. Vergote I, De Brabanter J, Fyles A. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet. 2001;357:176–182
  40. Gershenson DM, Silva EG. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer. 1990;65:578–585
  41. Lehner R, Szabo S, Goharkhy N, Jirecek S, Tringler B, Sevelda P. Prognostic influence of delays between exploratory and definitive laparotomy in the treatment of malignant ovarian tumors. Arch Gynecol Obstet. 2001;265:36–39
  42. Aletti GD, Long HJ, Podratz KC, Cliby WA. Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?. Gynecol Oncol. 2007;104:212–216
  43. Lecuru F, Desfeux P, Camatte S, Bissery A, Blanc B, Querleu D. Impact of initial surgical access on staging and survival of patients with stage I ovarian cancer. Int J Gynecol Cancer. 2006;16:87–94
  44. Ghezzi F, Cromi A, Uccella S, Bergamini V, Tomera S, Franchi M, et al. Laparoscopy versus laparotomy for the surgical management of apparent early stage ovarian cancer. Gynecol Oncol. 2007;105:409–413
  45. Young RC, Decker DG, Wharton JT, Piver MS, Sindelar WF, Edwards BK, et al. Staging laparotomy in early ovarian cancer. JAMA. 1983;250:3072–3076

 L.M. has nothing to disclose. I.P. has nothing to disclose. M.S. has nothing to disclose. M.C. has nothing to disclose. F.P. has nothing to disclose. R.A. has nothing to disclose. P.B.P. has nothing to disclose.

PII: S0015-0282(08)00728-0

doi: 10.1016/j.fertnstert.2008.03.058

Fertility and Sterility
Volume 91, Issue 6 , Pages 2632-2637 , June 2009

Article Tools